SIRPα/CD47 axis controls the maintenance of transplant tolerance sustained by myeloid-derived suppressor cells

Autor: Pengam, Sabrina, Durand, Justine, Usal, Claire, Gauttier, Vanessa, Dilek, Nahzli, Martinet, Bernard, Daguin, Véronique, Mary, Caroline, Thepenier, Virginie, Teppaz, Géraldine, Renaudin, Karine, Blancho, Gilles, Vanhove, Bernard, Poirier, Nicolas ^*

Publikováno v: In American Journal of Transplantation December 2019 19(12):3263-3275

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

CD4⁺ and CD8⁺ regulatory T cell characterization in the rat using a unique transgenic Foxp3-EGFP model.

Autor: Ménoret, Séverine, Tesson, Laurent, Remy, Séverine, Gourain, Victor, Sérazin, Céline, Usal, Claire, Guiffes, Aude, Chenouard, Vanessa, Ouisse, Laure-Hélène, Gantier, Malika, Heslan, Jean-Marie, Fourgeux, Cynthia, Poschmann, Jeremie, Guillonneau, Carole, Anegon, Ignacio

Publikováno v: BMC Biology; 1/12/2023, Vol. 21 Issue 1, p1-16, 16p

IL‐34 deficiency impairs FOXP3⁺ Treg function in a model of autoimmune colitis and decreases immune tolerance homeostasis.

Autor: Freuchet, Antoine, Salama, Apolline, Bézie, Séverine, Tesson, Laurent, Rémy, Séverine, Humeau, Romain, Règue, Hadrien, Sérazin, Céline, Flippe, Léa, Peterson, Pärt, Vimond, Nadège, Usal, Claire, Ménoret, Séverine, Heslan, Jean‐Marie, Duteille, Franck, Blanchard, Frédéric, Giral, Magali, Colonna, Marco, Anegon, Ignacio, Guillonneau, Carole

Publikováno v: Clinical & Translational Medicine; Aug2022, Vol. 12 Issue 8, p1-18, 18p

Cross-Reactive Donor-Specific CD8+ Tregs Efficiently Prevent Transplant Rejection

Autor: Picarda, Elodie, Bézie, Séverine, Usero, Lorena, Ossart, Jason, Besnard, Marine, Halim, Hanim, Echasserieau, Klara, Usal, Claire, Rossjohn, Jamie, Bernardeau, Karine, Gras, Stéphanie, Guillonneau, Carole

Publikováno v: Cell Reports
Cell Reports, Elsevier Inc, 2019, 29 (13), pp.4245-4255.e6. ⟨10.1016/j.celrep.2019.11.106⟩
Cell Reports, Vol 29, Iss 13, Pp 4245-4255.e6 (2019)
Cell Reports, 2019, 29 (13), pp.4245-4255.e6. ⟨10.1016/j.celrep.2019.11.106⟩

Summary: To reduce the use of non-specific immunosuppressive drugs detrimental to transplant patient health, therapies in development aim to achieve antigen-specific tolerance by promoting antigen-specific regulatory T cells (Tregs). However, identif

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6298f77d8fd01b1615286d2963f52b64
https://www.hal.inserm.fr/inserm-02449068/file/PIIS2211124719316298.pdf